Neuroleptics anxiety disorders

Leis AA, Kofler M, Stokic DS, et al Effect of the inhibitory phenomenon following magnetic stimulation of cortex on brainstem motor neuron excitability and on the cortical control of brainstem reflexes. Muscle Nerve 16 1351-1358, 1993 Lemke MR Effect of carbamazepine on agitation in Alzheimer s inpatients refractory to neuroleptics. J Clin Psychiatry 56 354-357, 1995 Lemus CZ, Robinson DG, Kronig M, et al Behavioral responses to a dopaminergic challenge in obsessive-compulsive disorder. J Anxiety Disord 5 369-373, 1991 Lena C, Changeux JP Allosteric modulations of the nicotinic acetylchohne receptor. Trends Neurosci 16 181-186, 1993... 

Richelson E, Nelson A Antagonism by neuroleptics of neurotransmitter receptors of normal brain in vitro. Eur J Pharmacol 103 197-204, 1984 Rickels K, Schweizer E The treatment of generalized anxiety disorder in patients with depressive symptomatology. J Clin Psychiatry 54 [suppl) 20-23, 1993 Rickels K, Weisman K, Norstad N, et al Buspirone and diazepam in anxiety a controlled study. J Chn Psychiatry 43(12 pt 2) 81-86, 1982 Rickels K, Feighner JP, Smith WT Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression. Arch Gen Psychiatry 42 134-141, 1985 Rickels K, Schweizer E, Weiss S, et al Maintenance drug treatment for panic disorder, 11 short- and long-term outcome after drug taper. Arch Gen Psychiatry 50 61-68, 1993... 

ADHD should not be diagnosed if the symptoms can be better accounted for by other mental disorders, such as mood disorder, Tourette s syndrome, anxiety disorder, dissociative disorder, personality disorder, personality change due to a general medical condition, or a substance-related disorder (e.g., due to bronchodilators, isoniazid, akathisia from neuroleptics). Moreover, ADHD is not diagnosed when symptoms occur exclusively during the course of a pervasive developmental disorder or psychotic disorder (American Psychiatric Association, 2000). Conditions other than ADHD, such as neurofibromatosis, fetal alcohol syndrome and lead poisoning, of which ADHD features are typical symptoms (Pearl et al., 2001), should also be ruled out. 

Patients seen for flashbacks are treated with oral diazepam (15—30 mg/day for adults) if symptoms of anxiety are severe (Rumack 1987). Neuroleptics, especially haloperidol, have been implicated in a transient increase in visual flashbacks and are not recommended (Moskowitz 1971 Strassman 1984). Risperidone and selective serotonin reuptake inhibitors may also worsen symptoms of hallucinogen persisting perception disorder (Halpern and Pope 2003). The patient needs assurance of the self-limiting nature of the phenomenon and its decreasing frequency of reoccurrence with time. The patient should be reminded that any future use of hallucinogens or marijuana may precipitate similar symptoms (Strassman 1984). 

Non-motor signs of the disorder are also treatable with symptomatic medications. The frequent mood disorder can be treated with standard antidepressants, including tricyclics (such as amitryptiline) or serotonin reuptake inhibitors (SSRIs, such as fluoxetine or sertraline). This treatment is not without risks in these patients, as it may trigger manic episodes or may even precipitate suicide. Anxiety responds to benzodiazepines, as well as to effective treatment of depression. Long-acting benzodiazepines are favored over short-acting ones because of the lesser abuse potential. Some of the behavioral abnormalities may respond to treatment with the neuroleptics as well. The use of atypical neuroleptics, such as clozapine is preferred over the typical neuroleptics as they may help to control dyskinesias with relatively few extrapyramidal side-effects (Ch. 54). 

Initially, the neuroleptics were used to manage severe anxiety, agitation, and aggression in individuals with severe mental illness such as schizophrenia, a psychotic illness characterized by delusions, hallucinations, and disorganized, illogical thinking. The first neuroleptic used in schizophrenia was chlorpromazine (Thorazine) in 1952. Additional neuroleptics were later developed to treat a variety of other disorders and conditions in children and adults, including autism, attention-deficit hyperactivity disorder (ADHD), bipolar dis-... 

Akathisia is a variant of the restless legs syndrome associated with anxiety and/or dysphoria (SEDA-19, 44) (SEDA-20, 36) (209-211). It can be confused with an exacerbation of the disorder being treated. Suicidal tendencies can occur in psychotic patients who developed neuroleptic-induced akathisia (212). On the other hand, recent evidence suggests that depressive symptoms may not be induced or worsened, and may even be reduced, by prescribing atypical neuroleptic drugs (213-215). Subjects show various degrees of restlessness and an inability to sit or stand still in severe cases, the presentation can merge with behavioral disorders. 

Antidepressant, anxiolytic, and neuroleptic drugs can allow some patients to participate in treatment programs, especially when drug abuse is associated with psychiatric disorders such as depression, chronic anxiety, or schizophrenia. 

Some of them are useful in the treatment of psychotic disorders, anxiety, pain, gastrointestinal dysfunction associated with dyspepsia, peptic ulcer, reflex esophagitis, flatulence (SO). Cyclindole (206) and flucindole (207) are neuroleptic agents (77,123). Cyclindole shows antidepressant activity while flucindole shows antipsychotic activity. 

---